JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257852

Human AZI2 knockout HeLa cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

AZI2 KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and 7 bp deletion in exon2.

View Alternative Names

5-azacytidine-induced protein 2, AA410145, AZ2, AZI2_HUMAN, MGC112644, NAP-1, NF-kappa-B-activating kinase-associated protein 1, Nak-associated protein 1, TILP, TILP(S)

1 Images
Western blot - Human AZI2 knockout HeLa cell lysate (AB257852)
  • WB

Lab

Western blot - Human AZI2 knockout HeLa cell lysate (AB257852)

Lane 1 : Wild-type HeLa cell lysate 20 μg
Lane 2 : AZI2 CRISPR-Cas9 edited HeLa cell lysate 20 μg
Lane 3 : HEK-293 cell lysate 20 μg
Lane 4 : Daudi cell lysate 20 μg
False colour image of Western blot : Anti-AZI2 antibody [EPR14698] - C-terminal staining at 1/5000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (ab7291) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab192253 was shown to bind specifically to AZI2. A band was observed at 45 kDa in wild-type HeLa cell lysates with no signal observed at this size in AZI2 CRISPR-Cas9 edited cell line ab265686 (CRISPR-Cas9 edited cell lysate ab257852). The band observed in the CRISPR-Cas9 edited lysate lane below 45 kDa is likely to represent a truncated form of AZI2. This has not been investigated further and the functional properties of the gene product have not been determined. To generate this image, wild-type and AZI2 CRISPR-Cas9 edited HeLa cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-AZI2 antibody [EPR14698] - C-terminal (<a href='/en-us/products/primary-antibodies/azi2-antibody-epr14698-c-terminal-ab192253'>ab192253</a>) at 1/5000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

AZI2 CRISPR-Cas9 edited HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human AZI2 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-azi2-knockout-hela-cell-line-ab265686'>ab265686</a>)

Lane 3:

HEK-293 cell lysate at 20 µg

Lane 4:

Daudi cell lysate at 20 µg

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Knockout validation

Sanger Sequencing,Western blot

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon2 and 7 bp deletion in exon2.

Disease

Adenocarcinoma

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257852-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human AZI2 knockout HeLa cell lysate", "number":"AB257852-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB257852-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
AZI2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AZI2 also known as Nak-associated protein 1 (NAP1) is a regulatory protein with a molecular mass of about 55 kDa. Its primary role involves interaction with other molecules to help signal transduction in cells. AZI2 mainly express in tissues that are involved in immune responses such as the spleen and lymph nodes. It functions through modulating the activation of signaling pathways critical for cellular responses to various stimuli.
Biological function summary

AZI2 plays an essential role in the immune system. It is part of a signaling complex that includes other proteins such as TANK and TRAF6. This complex contributes to the activation of NF-kB transcription factors. AZI2 is involved in cellular processes like inflammation and response to stress by regulating the activity of NF-kB an important transcription factor. This regulatory activity underlines AZI2's significance in maintaining immune system homeostasis.

Pathways

AZI2 is closely associated with the toll-like receptor (TLR) and TNF receptor signaling pathways. These pathways orchestrate immune cell responses to microbial infections and inflammation. In these pathways AZI2 interacts with proteins like IKK epsilon and TANK to mediate NF-kB activation. These interactions help transduce signals from membrane-bound receptors to the nucleus promoting the expression of immune response genes.

Aberrant AZI2 function can link to autoimmune diseases and certain cancers. Disruption of AZI2-related signaling pathways can lead to improper immune system activation contributing to autoimmune diseases like rheumatoid arthritis. In cancer altered AZI2 expression can affect pathways that control cell survival and proliferation. Through these diseases AZI2 has associations with key regulatory proteins like TRAF3 and TBK1 which play roles in modulating immune responses and cellular growth.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com